GSK to name consumer healthcare unit ‘Haleon’ after spin-off
– GlaxoSmithKline said on Tuesday its consumer healthcare venture with Pfizer will be named Haleon, as the British drugmaker confirmed the business will be spun off in mid-2022 as planned after having…